CURACHEM Co., ltd.
Synthesizes 14C radioisotope-labeled compounds for ADME testing of new drug candidates.
As of 2026-10-08, CURACHEM Co., ltd. has 6 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2009 as AvidScience and renamed Curachem the same year, and listed on KONEX in 2023, the company specializes in synthesizing radioisotope-labeled compounds. It synthesizes compounds labeled with the carbon radioisotope 14C for ADME (absorption, distribution, metabolism, excretion) testing of new drug candidates, and has offered GMP synthesis services since 2018. It has collaborated with Japan's Nemoto (2010) and LSIM (2011), passed a GMP audit by ICON, the world's third-largest CRO, to win a synthesis services contract in 2022, and has been the sole domestic provider of radioisotope-labeled compound synthesis services since Korea Radiolabeled Compound Institute stopped the business in 2018.
Products & technology
- Radioisotope (14C) labeled compound synthesis serviceSynthesis of labeled compounds for ADME testing of new drug candidates
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Design, synthesis, and biological evaluation of pseudo-bicyclic pyrimidine-based compounds as potential EGFR inhibitors.
Bioorganic chemistry · 2022-09 · Farag AK, Ahn BS, Yoo JS 외 2
- AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer Cells.
Cancers · 2022-06 · Jeong S, Farag AK, Yun HK 외 10
- Design, synthesis, and biological evaluation of novel pyrido-dipyrimidines as dual topoisomerase II/FLT3 inhibitors in leukemia cells.
Bioorganic chemistry · 2022-05 · Abdelgawad MA, Mohamed FEA, Lamie PF 외 11
- AKF-D52, a Synthetic Phenoxypyrimidine-Urea Derivative, Triggers Extrinsic/Intrinsic Apoptosis and Cytoprotective Autophagy in Human Non-Small Cell Lung Cancer Cells.
Cancers · 2021-11 · Gil HS, Lee JH, Farag AK 외 5
- Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery.
Life (Basel, Switzerland) · 2021-10 · Al-Sanea MM, Chilingaryan G, Abelyan N 외 9
- Synthesis of di-docosahexaenoyl (C22:6)-bis(monoacylglycerol) phosphate in unlabelled and C-13 labelled forms for use as a biomarker of drug induced phospholipidosis.
Journal of labelled compounds & radiopharmaceuticals · 2019-09 · Hickey MJ, Lindqvist J, Ha YH 외 2
Patents
KIPRIS · applicant-matchedPCT · Published · 2009-09 · Application PCT/KR2009/005307
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot5
- AnthropicClaudeBot2
- MicrosoftBingbot1
- PerplexityPerplexityBot1
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 1, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for CURACHEM Co., ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryMedical Devices
Interojo, founded 2000 and KOSDAQ-listed 2010, manufactures contact lenses under its Clalen brand domestically and via OEM/ODM overseas.
MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
Founded in 2012 and listed on KOSDAQ in 2026, REMEDI develops portable X-ray imaging devices based on its low-dose, miniaturized X-ray technology.
KOSDAQ-listed medical device company developing the LOTUS and HELIOS laser aesthetic devices and the PALLAS vitiligo treatment device.
Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.
Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded in 2010 and KOSDAQ-listed in 2018, Dynamic Solution makes AI/IoT-based rehabilitation devices like the Rapael Smart Glove.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition